TrialBMC cancer2021

Comparing the efficacy and side-effects of PDLASTA® (Pegfilgrastim) with PDGRASTIM® (Filgrastim) in breast cancer patients: a non-inferiority randomized clinical trial.

Safa Najafi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.